StockData
Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc. (ORGO) stock

ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$0.85+0.04 (+5.13%)

Close on Nov 18, 2026Market cap $109.78MP/E –Yield –

Organogenesis pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Organogenesis's pe ratio was 112.2× on Jul 31, 2026, against 75.5× a year earlier. Over the last 5 years it ranged from 5.8× to 906.8×, with a median of 38.8×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 2026112.2×−542.0
2025Dec 31, 2025654.1×+578.6
2024Jul 31, 202475.5×+34.6
2023Dec 29, 202340.9×+34.8
2022Dec 30, 20226.1×−14.4
2021Dec 31, 202120.5×−153.5
2017Oct 31, 2017174.0×–

More Organogenesis figures

See a number that looks wrong?